Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Pneumonia, Pneumococcal 1Pneumococcal Infections 1Multiple Myeloma 1Febrile Neutropenia 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 3Radiotherapy 3Propranolol 3Cisplatin 3entecavir 2Tranexamic Acid 2Pemetrexed 2Metformin 2Erythromycin 2Epinephrine 2Cyclophosphamide 2Chemoradiotherapy 2Bortezomib 2ulipristal acetate 1tislelizumab 1plerixafor 1lobaplatin 1ledipasvir 1eribulin 1endostar protein 1dolutegravir 1colistinmethanesulfonic acid 1cetrorelix 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1XELOX 1Vancomycin 1Vacuum Curettage 1Vaccination 1Suction 1Sofosbuvir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × OTHER_GOV × Vaccination × Clear all
NCT03619252 2022-08-31

Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology

Phase 4 Completed
36 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Pneumococcal Infections, Pneumonia, Pneumococcal, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡